There are 2789 resources available
337TiP - An open-label, phase Ib/II study to evaluate the safety and efficacy of fruquintinib in combination with tislelizumab in patients with advanced triple-negative breast cancer
Presenter: Debu Tripathy
Session: ePoster Display
338TiP - CAPItello-292: A phase 1b/3 study of capivasertib, palbociclib and fulvestrant versus placebo, palbociclib and fulvestrant in HR+/HER2− advanced breast cancer
Presenter: Erika Hamilton
Session: ePoster Display
339TiP - SOLTI-1502 ARIANNA: Targeting PAM50 HER2-enriched intrinsic subtype with enzalutamide in hormone receptor-positive/HER2-negative metastatic breast cancer
Presenter: Luis Manso
Session: ePoster Display
348P - Up-regulation of sorcin promotes glioblastoma progression via activating the PI3K/AKT/mTOR pathway
Presenter: Zhangya Pu
Session: ePoster Display
349P - The amount of cancer stem cells and the sensitivity to anticancer drugs in glioblastoma primary cell culture
Presenter: Olga Susova
Session: ePoster Display
350P - Molecular profiling of tumor tissue and tumor-derived cell lines in patients with glioblastoma
Presenter: Tatiana Nasedkina
Session: ePoster Display
455P - Concordance of baseline RAS mutational status (ms) between tissue and cell-free DNA (cfDNA) and association with overall response rate (ORR) in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study (cohort 2) (NCT02792478)
Presenter: Manuel Valladares-Ayerbes
Session: ePoster Display
456P - Prognostic and predictive value of tumor-infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer
Presenter: Safa Can Efil
Session: ePoster Display
457P - Circulating tumor DNA (ctDNA) from patients (pts) with advanced colorectal cancer (CRC) is enriched for EGFR extracellular domain (ECD) mutations
Presenter: Sabine Tejpar
Session: ePoster Display
458P - Circulating tumor DNA analysis predicting recurrence risk in patients with stage I-III colorectal cancer
Presenter: Jin Gu
Session: ePoster Display